SynCore Biotechnology Correlations
4192 Stock | TWD 36.40 0.10 0.28% |
The current 90-days correlation between SynCore Biotechnology and OBI Pharma is -0.05 (i.e., Good diversification). The correlation of SynCore Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
SynCore Biotechnology Correlation With Market
Significant diversification
The correlation between SynCore Biotechnology Co and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and DJI in the same portfolio, assuming nothing else is changed.
SynCore |
The ability to find closely correlated positions to SynCore Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SynCore Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SynCore Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SynCore Biotechnology Co to buy it.
Moving together with SynCore Stock
0.86 | 4743 | Oneness Biotech | PairCorr |
0.89 | 6547 | Medigen Vaccine Biologics | PairCorr |
0.83 | 4174 | OBI Pharma | PairCorr |
0.88 | 4142 | Adimmune Corp | PairCorr |
0.84 | 2891C | CTBC Financial Holding | PairCorr |
0.8 | 2888 | Shin Kong Financial Earnings Call This Week | PairCorr |
Moving against SynCore Stock
0.87 | 2882B | Cathay Financial Holding | PairCorr |
0.87 | 2891 | CTBC Financial Holding | PairCorr |
0.86 | 2891B | CTBC Financial Holding | PairCorr |
0.84 | 2881A | Fubon Financial Holding | PairCorr |
0.75 | 2881B | Fubon Financial Holding | PairCorr |
0.73 | 2330 | Taiwan Semiconductor | PairCorr |
0.72 | 0050 | YuantaP shares Taiwan | PairCorr |
0.71 | 0057 | Fubon MSCI Taiwan | PairCorr |
0.68 | 2882A | Cathay Financial Holding Earnings Call Tomorrow | PairCorr |
0.68 | 2882 | Cathay Financial Holding | PairCorr |
0.67 | 4162 | PharmaEngine | PairCorr |
0.63 | 0053 | YuantaP shares Taiwan | PairCorr |
0.45 | 6589 | EirGenix | PairCorr |
Related Correlations Analysis
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.
Be your own money manager
Our tools can tell you how much better you can do entering a position in SynCore Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
SynCore Biotechnology Corporate Management
Elected by the shareholders, the SynCore Biotechnology's board of directors comprises two types of representatives: SynCore Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SynCore. The board's role is to monitor SynCore Biotechnology's management team and ensure that shareholders' interests are well served. SynCore Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SynCore Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
ChiaHao Liang | Senior Manager of Finance & Accounting | Profile | |
MuhHwan Su | General Manager | Profile | |
WenHsin Huang | VP Department | Profile | |
FernFang Lin | VP Devel | Profile | |
CharnJung Chang | General Manager-Ophthalmology Project | Profile | |
HuiHung MBA | VP Drugs | Profile |